Ketorolac (Toradol) IV Push Administration Guidelines
Ketorolac 30mg IVP should not be administered as it exceeds the recommended single intravenous dose of 15-30mg, which should be given over 15-30 minutes rather than as a rapid push. 1
Appropriate IV Administration of Ketorolac
Ketorolac tromethamine (Toradol) is a potent non-steroidal anti-inflammatory drug (NSAID) with significant analgesic properties. When administering intravenously, follow these guidelines:
Correct dosing:
Administration method:
- Dilute and administer as a slow IV infusion over 15-30 minutes
- Rapid IV push administration increases risk of adverse effects including pain at injection site and potential cardiovascular complications
Patient Selection and Contraindications
Ketorolac should only be used in appropriate patients:
Contraindications:
Use with caution in:
Efficacy and Clinical Applications
Ketorolac is effective for:
- Moderate to severe acute pain management 2
- Postoperative pain (rated 3 out of 4 for efficacy in clinical studies) 2
- Reducing opioid requirements when used as part of multimodal analgesia 1
Adverse Effects and Monitoring
Monitor for these potential adverse effects:
Common side effects:
- Edema
- Drowsiness
- Dizziness
- GI upset
- Increased diaphoresis 2
Serious concerns:
- Renal effects: Monitor renal function, especially in at-risk patients
- GI bleeding: Higher risk in elderly and those with prior GI issues
- Cardiovascular events: Risk of thrombotic events, particularly with prolonged use
- Anaphylactic reactions (rare but potentially fatal) 4
Alternative Approaches
If ketorolac is contraindicated or inappropriate:
- Alternative analgesics:
Key Takeaway
Ketorolac is a potent analgesic, but proper administration technique is crucial for safety. The 30mg dose should be administered as a slow IV infusion over 15-30 minutes, not as a rapid IV push. Always verify appropriate patient selection, contraindications, and monitor for adverse effects.